PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2024-12-16

Date Title Company
16-Dec-2024 Scailyte and Visterra Partner to Advance Autoimmune Disease Research Newswire
16-Dec-2024 Cloud DX Completes First Stage of Restructuring Process AccessWire
16-Dec-2024 Medical Tubing Market Acumen Research and Consulting
16-Dec-2024 Kairos Pharma to Participate in The Microcap Conference in January 2025 AccessWire
16-Dec-2024 New OHE research finds productivity losses from respiratory infections cost UK businesses £44 billion per year OHE
16-Dec-2024 GenesisCare UK successfully completes refinancing transaction and raises financing for growth GenesisCare UK
16-Dec-2024 Celltrion receives positive CHMP opinion for three biosimilars in the European Union Celltrion
16-Dec-2024 NeoPhore appoints Michael Shih as Chief Executive Officer NeoPhore
16-Dec-2024 PureTech’s Deupirfenidone (LYT-100) Slowed Lung Function Decline in People with Idiopathic Pulmonary Fibrosis (IPF) as Measured by Forced Vital Capacity (FVC) PureTech
16-Dec-2024 ViroCell Biologics expands U.S. business development team with two new appointments ViroCell Biologics
16-Dec-2024 New Model for Evaluating Hospital Decision-Making Developed by Hebrew University Researchers Hebrew University of Jerusalem
16-Dec-2024 Changes in the management of SCANLAB SCANLAB
16-Dec-2024 Black Book Research Releases 2025 Global HIT Study: Client Ratings of 175 EHR Vendors Across 110 Countries AccessWire
16-Dec-2024 Managing Medicare Advantage Plan Challenges with Your Hospital’s Swing Bed Program AccessWire
16-Dec-2024 Concinnity Genetics raises £3m to establish unique RNA-based control systems for precise control of gene therapies in oversubscribed round Concinnity Genetics
16-Dec-2024 Applied DNA to Report Fourth Quarter and Fiscal Year 2024 Financial Results After Market Close on December 17, 2024; Sets Webcast and Conference Call for January 9, 2025, to Coincide with Update on GMP Manufacturing Facility Build-out AccessWire
16-Dec-2024 Scailyte and Visterra Partner to Advance Autoimmune Disease Research AccessWire
16-Dec-2024 Xenetic Biosciences, Inc. Extends Research Agreement with the University of Virginia for the Advancement of its DNase-Based Oncology Platform AccessWire
16-Dec-2024 Avenir Wellness Solutions Announces Global Settlement with Ionic Ventures, Eliminating Convertible Debt AccessWire
16-Dec-2024 Dermata Receives Approval from FDA for the Proprietary Name Xyngari(TM) AccessWire